Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ERC1 antisense RNA 1 (ERC1-AS1)
- Target
- ERC1-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA (Natural antisense transcript, NAT)
01
Overview
ERC1 antisense RNA 1 (ERC1-AS1) is a long non-coding RNA (lncRNA) transcribed in the antisense orientation relative to the ERC1 gene, which encodes a member of the RIM-binding protein family involved in neurotransmitter release. ERC1-AS1, like other antisense lncRNAs, likely regulates the expression or stability of the ERC1 mRNA or other genes by mechanisms such as transcript hybridization or recruitment of regulatory proteins. While many antisense lncRNAs are emerging as important in gene regulation and are implicated in various diseases, there are currently no reports directly linking ERC1-AS1 to specific biological functions or pathologies, and it is not recognized as a therapeutic target[1][5].
02
Mechanism of action
Not applicable; no drugs or small molecules are known to directly target this non-coding RNA.
03
Biological functions
Regulation of gene expression (typically at the transcriptional or post-transcriptional level)May regulate the expression and function of the nearby or overlapping ERC1 gene (RIM-binding protein involved in neurotransmitter release)
04
Disease associations
No direct disease roles are documented for ERC1-AS1 specifically as of current data, but as lncRNAs, antisense RNAs often play roles in gene regulation with potential implications in diseases when dysregulated
05
Safety considerations
None reported; as ERC1-AS1 is not a drug target, safety profiles are not available.
Beyond the preview
Go deeper on ERC1 antisense RNA 1 (ERC1-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ERC1 antisense RNA 1 (ERC1-AS1).